(19)
(11) EP 4 351 619 A1

(12)

(43) Date of publication:
17.04.2024 Bulletin 2024/16

(21) Application number: 22820898.9

(22) Date of filing: 07.06.2022
(51) International Patent Classification (IPC): 
A61K 38/095(2019.01)
A61P 13/12(2006.01)
 A61P 1/16(2006.01)
G01N 33/50(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/095; A61P 13/12; A61P 1/16; A61K 9/0019
(86) International application number:
PCT/US2022/032511
(87) International publication number:
WO 2022/261102 (15.12.2022 Gazette 2022/50)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 07.06.2021 US 202117340765

(71) Applicant: Mallinckrodt Pharmaceuticals Ireland Limited
Dublin 15 (IE)

(72) Inventors:
  • TEUBER, Peter
    Hazelwood, Missouri 63042 (US)
  • PAPPAS, Stephen Chris
    Dublin 15 (IE)
  • JAMIL, Khurram
    Dublin 15 (IE)

(74) Representative: Jones, Nicholas Andrew 
Withers & Rogers LLP 2 London Bridge
London SE1 9RA
London SE1 9RA (GB)

   


(54) METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1